These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 5085230

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD, Shanks RG, Zaidi SA.
    Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
    [Abstract] [Full Text] [Related]

  • 3. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
    Allen JD, Shanks RG.
    Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B, Jordan R, Loveless AH, Maxwell DR.
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [Abstract] [Full Text] [Related]

  • 5. Effect of alinidine on experimental cardiac arrhythmias.
    Harron DW, Allen JD, Wilson R, Shanks RG.
    J Cardiovasc Pharmacol; 1982 Mar; 4(2):221-5. PubMed ID: 6175804
    [Abstract] [Full Text] [Related]

  • 6. Effect of 8-(3-diethylaminopropyl)-6,6-dimethyl-(2-phenyl-1 H-imidazo(4,5 h))isoquinoline-7,9-(6H)-dione dihydrochloride (AR-LH31) on experimental cardiac arrhythmias in dogs.
    Kerr MJ, Harron DW, Wilson R, Shanks RG.
    Arzneimittelforschung; 1985 Mar; 35(1A):197-200. PubMed ID: 3838674
    [Abstract] [Full Text] [Related]

  • 7. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I, Hashimoto K, Katano Y, Tsukada T, Matsuda H.
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [Abstract] [Full Text] [Related]

  • 8. The effect of experimental cardiac arrhythmias of a new anticonvulsant agent, Kö 1173, and its comparison with phenytoin and procainamide.
    Allen JD, Kofi JM, Shanks RG, Zaidi SA.
    Br J Pharmacol; 1970 May; 39(1):183P-184P. PubMed ID: 4192640
    [No Abstract] [Full Text] [Related]

  • 9. Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
    Uprichard AG, Harron DW, Wilson R, Shanks RG.
    Br J Pharmacol; 1988 Dec; 95(4):1241-54. PubMed ID: 2905912
    [Abstract] [Full Text] [Related]

  • 10. The antiarrhythmic properties of BL-3677A.
    Buyniski JP, Gardier RW.
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of the effects of quinetholate, lidocaine and procainamide on ouabain-induced ventricular tachycardia and cardiac function.
    Taylor SE, Nash CB.
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):279-90. PubMed ID: 677962
    [Abstract] [Full Text] [Related]

  • 12. Mexiletine (Kö 1173) in the management of ventricular dysrhythmias.
    Campbell NP, Kelly JG, Shanks RG, Chaturvedi NC, Strong JE, Pantridge JF.
    Lancet; 1973 Aug 25; 2(7826):404-7. PubMed ID: 4124890
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of ventricular arrhythmias with mexiletine (Kö 1173).
    Talbot RG, Nimmo J, Julian DG, Clark RA, Neilson JM, Prescott LF.
    Lancet; 1973 Aug 25; 2(7826):399-404. PubMed ID: 4124889
    [No Abstract] [Full Text] [Related]

  • 14. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T, Hashimoto N.
    Arzneimittelforschung; 1968 Oct 25; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract] [Full Text] [Related]

  • 15. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C, Sanna GP, Turba C.
    Arzneimittelforschung; 1968 Jul 25; 18(7):845-50. PubMed ID: 5755831
    [No Abstract] [Full Text] [Related]

  • 16. Effect of KO 1173, a new antiarrhythmic drug, on contractile state of diseased left ventricle and on frequency of 'stable' premature beats.
    Shaw TR, Royds R.
    Br Heart J; 1973 May 25; 35(5):558. PubMed ID: 4716039
    [No Abstract] [Full Text] [Related]

  • 17. [Modification by lidocain and other anti-arrhythmia agents on the combination of fixed and variably coupled ectopic ventricular beats].
    Burkhardt D, Steinbrunn W, Kaufmann G.
    Schweiz Med Wochenschr; 1973 Dec 15; 103(50):1787-9. PubMed ID: 4768697
    [No Abstract] [Full Text] [Related]

  • 18. Procainamide in the dog: antiarrhythmic plasma concentrations after intravenous administration.
    Papich MG, Davis LE, Davis CA.
    J Vet Pharmacol Ther; 1986 Dec 15; 9(4):359-69. PubMed ID: 3806778
    [Abstract] [Full Text] [Related]

  • 19. Effect of several anticonvulsant drugs and procainamide against ouabain-induced cardiac arrhythmias in rabbits.
    Dressler WE, Rossi GV, Orzechowski RF.
    J Pharm Sci; 1972 Jan 15; 61(1):133-4. PubMed ID: 4400512
    [No Abstract] [Full Text] [Related]

  • 20. Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs.
    Shibuya T, Hashimoto K, Imai S.
    J Cardiovasc Pharmacol; 1983 Jan 15; 5(4):538-45. PubMed ID: 6193348
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.